Cutaneous innate immune sensing of toll-like receptor 2-6 ligands suppresses T cell immunity by inducing myeloid-derived suppressor cells

Immunity

Volumn 41, Issue 5, 2014, Pages 762-775

  Skabytska, Yuliya ^a   Wölbing, Florian ^a   Günther, Claudia ^b   Köberle, Martin ^a,c   Kaesler, Susanne ^a   Chen, Ko Ming ^a   Guenova, Emmanuella ^a,d   Demircioglu, Doruk ^a   Kempf, Wolfgang E ^a,c   Volz, Thomas ^a,c   Rammensee, Hans Georg ^a   Schaller, Martin ^a   Röcken, Martin ^a   Götz, Friedrich ^a   Biedermann, Tilo ^a,c  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; INTERLEUKIN 6; LIPOPEPTIDE; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 6; ANTIGEN; MYD88 PROTEIN, MOUSE; MYELOID DIFFERENTIATION FACTOR 88; TLR2 PROTEIN, MOUSE; TLR4 PROTEIN, MOUSE; TLR6 PROTEIN, MOUSE; TOLL LIKE RECEPTOR 1;

ARTICLE; ATOPIC DERMATITIS; CELLULAR IMMUNITY; HUMAN; IMMUNE RESPONSE; INNATE IMMUNITY; MOUSE; MYELOID DERIVED SUPPRESSOR CELL; NONHUMAN; SKIN INFECTION; STAPHYLOCOCCUS AUREUS; SUPPRESSOR CELL; T LYMPHOCYTE ACTIVATION; ADAPTIVE IMMUNITY; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; BONE MARROW CELL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; LYMPHOCYTE ACTIVATION; MICROBIOLOGY; SKIN; STAPHYLOCOCCAL SKIN INFECTION;

ADAPTIVE IMMUNITY; ANIMALS; ANTIGENS; ANTIGENS, CD11B; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DERMATITIS, ATOPIC; HUMANS; INTERLEUKIN-6; LIPOPEPTIDES; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; MYELOID CELLS; MYELOID DIFFERENTIATION FACTOR 88; SKIN; STAPHYLOCOCCAL SKIN INFECTIONS; STAPHYLOCOCCUS AUREUS; TOLL-LIKE RECEPTOR 1; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTOR 6;

EID: 84912135573     PISSN: 10747613     EISSN: 10974180     Source Type: Journal    
DOI: 10.1016/j.immuni.2014.10.009     Document Type: Article

References (51)

1. Arora M., Poe S.L., Oriss T.B., Krishnamoorthy N., Yarlagadda M., Wenzel S.E., Billiar T.R., Ray A., Ray P. TLR4/MyD88-induced CD11b+Gr-1 int F4/80+ non-migratory myeloid cells suppress Th2 effector function in the lung. Mucosal Immunol. 2010, 3:578-593.
2. Beck L.A., Boguniewicz M., Hata T., Schneider L.C., Hanifin J., Gallo R., Paller A.S., Lieff S., Reese J., Zaccaro D., et al. Phenotype of atopic dermatitis subjects with a history of eczema herpeticum. J.Allergy Clin. Immunol. 2009, 124:260-269. 269 e261-267.
3. Beck L.A., Thaçi D., Hamilton J.D., Graham N.M., Bieber T., Rocklin R., Ming J.E., Ren H., Kao R., Simpson E., et al. Dupilumab treatment in adults with moderate-to-severe atopic dermatitis. N.Engl. J. Med. 2014, 371:130-139.
4. Biedermann T. Dissecting the role of infections in atopic dermatitis. Acta Derm. Venereol. 2006, 86:99-109.
5. Biedermann T., Schwarzler C., Lametschwandtner G., Thoma G., Carballido-Perrig N., Kund J., de Vries J.E., Rot A., Carballido J.M. Targeting CLA/E-selectin interactions prevents CCR4-mediated recruitment of human Th2 memory cells to human skin in vivo. Eur. J. Immunol. 2002, 32:3171-3180.
6. Blander J.M., Medzhitov R. Regulation of phagosome maturation by signals from toll-like receptors. Science 2004, 304:1014-1018.
7. Bronte V. Myeloid-derived suppressor cells in inflammation: uncovering cell subsets with enhanced immunosuppressive functions. Eur. J. Immunol. 2009, 39:2670-2672.
8. Bunt S.K., Yang L., Sinha P., Clements V.K., Leips J., Ostrand-Rosenberg S. Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progression. Cancer Res. 2007, 67:10019-10026.
9. Buwitt-Beckmann U., Heine H., Wiesmüller K.H., Jung G., Brock R., Akira S., Ulmer A.J. TLR1- and TLR6-independent recognition of bacterial lipopeptides. J.Biol. Chem. 2006, 281:9049-9057.
10. Chalmin F., Ladoire S., Mignot G., Vincent J., Bruchard M., Remy-Martin J.P., Boireau W., Rouleau A., Simon B., Lanneau D., et al. Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells. J.Clin. Invest. 2010, 120:457-471.
11. Delano M.J., Scumpia P.O., Weinstein J.S., Coco D., Nagaraj S., Kelly-Scumpia K.M., O'Malley K.A., Wynn J.L., Antonenko S., Al-Quran S.Z., et al. MyD88-dependent expansion of an immature GR-1(+)CD11b(+) population induces Tcell suppression and Th2 polarization in sepsis. J.Exp. Med. 2007, 204:1463-1474.
12. Esparza-Gordillo J., Schaarschmidt H., Liang L., Cookson W., Bauerfeind A., Lee-Kirsch M.A., Nemat K., Henderson J., Paternoster L., Harper J.I., et al. A functional IL-6 receptor (IL6R) variant is a risk factor for persistent atopic dermatitis. J.Allergy Clin. Immunol. 2013, 132:371-377.
13. Fedenko E.S., Elisyutina O.G., Filimonova T.M., Boldyreva M.N., Burmenskaya O.V., Rebrova O.Y., Yarilin A.A., Khaitov R.M. Cytokine gene expression in the skin and peripheral blood of atopic dermatitis patients and healthy individuals. Self Nonself 2011, 2:120-124.
14. Gabrilovich D.I., Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat. Rev. Immunol. 2009, 9:162-174.
15. Gabrilovich D.I., Velders M.P., Sotomayor E.M., Kast W.M. Mechanism of immune dysfunction in cancer mediated by immature Gr-1+ myeloid cells. J.Immunol. 2001, 166:5398-5406.
16. Hajjar A.M., O'Mahony D.S., Ozinsky A., Underhill D.M., Aderem A., Klebanoff S.J., Wilson C.B. Cutting edge: functional interactions between toll-like receptor (TLR) 2 and TLR1 or TLR6 in response to phenol-soluble modulin. J.Immunol. 2001, 166:15-19.
17. Henneke P., Dramsi S., Mancuso G., Chraibi K., Pellegrini E., Theilacker C., Hübner J., Santos-Sierra S., Teti G., Golenbock D.T., et al. Lipoproteins are critical TLR2 activating toxins in group B streptococcal sepsis. J.Immunol. 2008, 180:6149-6158.
18. Hoetzenecker W., Echtenacher B., Guenova E., Hoetzenecker K., Woelbing F., Brück J., Teske A., Valtcheva N., Fuchs K., Kneilling M., et al. ROS-induced ATF3 causes susceptibility to secondary infections during sepsis-associated immunosuppression. Nat. Med. 2012, 18:128-134.
19. Jin M.S., Kim S.E., Heo J.Y., Lee M.E., Kim H.M., Paik S.G., Lee H., Lee J.O. Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide. Cell 2007, 130:1071-1082.
20. Kaesler S., Volz T., Skabytska Y., Koberle M., Hein U., Chen K.M., Guenova E., Wolbing F., Rocken M., Biedermann T. Toll-like receptor 2 ligands promote chronic atopic dermatitis through IL-4-mediated suppression of IL-10. J. Allergy Clin. Immunol. 2014, 134:92-99.
21. Kang J.Y., Nan X., Jin M.S., Youn S.J., Ryu Y.H., Mah S., Han S.H., Lee H., Paik S.G., Lee J.O. Recognition of lipopeptide patterns by Toll-like receptor 2-Toll-like receptor 6 heterodimer. Immunity 2009, 31:873-884.
22. Kawai T., Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat. Immunol. 2010, 11:373-384.
23. Kuo I.H., Carpenter-Mendini A., Yoshida T., McGirt L.Y., Ivanov A.I., Barnes K.C., Gallo R.L., Borkowski A.W., Yamasaki K., Leung D.Y., et al. Activation of epidermal toll-like receptor 2 enhances tight junction function: implications for atopic dermatitis and skin barrier repair. J.Invest. Dermatol. 2013, 133:988-998.
24. Kupper T.S., Fuhlbrigge R.C. Immune surveillance in the skin: mechanisms and clinical consequences. Nat. Rev. Immunol. 2004, 4:211-222.
25. Kurokawa K., Kim M.S., Ichikawa R., Ryu K.H., Dohmae N., Nakayama H., Lee B.L. Environment-mediated accumulation of diacyl lipoproteins over their triacyl counterparts in Staphylococcus aureus. J.Bacteriol. 2012, 194:3299-3306.
26. Kurokawa K., Ryu K.H., Ichikawa R., Masuda A., Kim M.S., Lee H., Chae J.H., Shimizu T., Saitoh T., Kuwano K., et al. Novel bacterial lipoprotein structures conserved in low-GC content gram-positive bacteria are recognized by Toll-like receptor 2. J.Biol. Chem. 2012, 287:13170-13181.
27. Kusmartsev S.A., Li Y., Chen S.H. Gr-1+ myeloid cells derived from tumor-bearing mice inhibit primary Tcell activation induced through CD3/CD28 costimulation. J.Immunol. 2000, 165:779-785.
28. Lai Y., Gallo R.L. Toll-like receptors in skin infections and inflammatory diseases. Infect. Disord. Drug Targets 2008, 8:144-155.
29. Lai Y., Di Nardo A., Nakatsuji T., Leichtle A., Yang Y., Cogen A.L., Wu Z.R., Hooper L.V., Schmidt R.R., von Aulock S., et al. Commensal bacteria regulate Toll-like receptor 3-dependent inflammation after skin injury. Nat. Med. 2009, 15:1377-1382.
30. Leung D.Y., Bieber T. Atopic dermatitis. Lancet 2003, 361:151-160.
31. Lowy F.D. Staphylococcus aureus infections. N.Engl. J. Med. 1998, 339:520-532.
32. Mae M., Iyori M., Yasuda M., Shamsul H.M., Kataoka H., Kiura K., Hasebe A., Totsuka Y., Shibata K. The diacylated lipopeptide FSL-1 enhances phagocytosis of bacteria by macrophages through a Toll-like receptor 2-mediated signalling pathway. FEMS Immunol. Med. Microbiol. 2007, 49:398-409.
33. Mempel M., Voelcker V., Köllisch G., Plank C., Rad R., Gerhard M., Schnopp C., Fraunberger P., Walli A.K., Ring J., et al. Toll-like receptor expression in human keratinocytes: nuclear factor kappaB controlled gene activation by Staphylococcus aureus is toll-like receptor 2 but not toll-like receptor 4 or platelet activating factor receptor dependent. J.Invest. Dermatol. 2003, 121:1389-1396.
34. Mühlradt P.F., Kiess M., Meyer H., Süssmuth R., Jung G. Isolation, structure elucidation, and synthesis of a macrophage stimulatory lipopeptide from Mycoplasma fermentans acting at picomolar concentration. J.Exp. Med. 1997, 185:1951-1958.
35. Müller P., Müller-Anstett M., Wagener J., Gao Q., Kaesler S., Schaller M., Biedermann T., Götz F. The Staphylococcus aureus lipoprotein SitC colocalizes with Toll-like receptor 2 (TLR2) in murine keratinocytes and elicits intracellular TLR2 accumulation. Infect. Immun. 2010, 78:4243-4250.
36. Naik S., Bouladoux N., Wilhelm C., Molloy M.J., Salcedo R., Kastenmuller W., Deming C., Quinones M., Koo L., Conlan S., et al. Compartmentalized control of skin immunity by resident commensals. Science 2012, 337:1115-1119.
37. Navarini A.A., French L.E., Hofbauer G.F. Interrupting IL-6-receptor signaling improves atopic dermatitis but associates with bacterial superinfection. J.Allergy Clin. Immunol. 2011, 128:1128-1130.
38. Ostrand-Rosenberg S., Sinha P. Myeloid-derived suppressor cells: linking inflammation and cancer. J.Immunol. 2009, 182:4499-4506.
39. Saeed K., Marsh P., Ahmad N. Cryptic resistance in Staphylococcus aureus: a risk for the treatment of skin infection?. Curr. Opin. Infect. Dis. 2014, 27:130-136.
40. Sasaki T., Kano R., Sato H., Nakamura Y., Watanabe S., Hasegawa A. Effects of staphylococci on cytokine production from human keratinocytes. Br. J. Dermatol. 2003, 148:46-50.
41. Schmaler M., Jann N.J., Ferracin F., Landolt L.Z., Biswas L., Götz F., Landmann R. Lipoproteins in Staphylococcus aureus mediate inflammation by TLR2 and iron-dependent growth invivo. J.Immunol. 2009, 182:7110-7118.
42. Stadnyk A.W. Cytokine production by epithelial cells. FASEB J. 1994, 8:1041-1047.
43. Stoll H., Dengjel J., Nerz C., Götz F. Staphylococcus aureus deficient in lipidation of prelipoproteins is attenuated in growth and immune activation. Infect. Immun. 2005, 73:2411-2423.
44. Swamy M., Jamora C., Havran W., Hayday A. Epithelial decision makers: in search of the 'epimmunome'. Nat. Immunol. 2010, 11:656-665.
45. Takashima A., Bergstresser P.R. Cytokine-mediated communication by keratinocytes and Langerhans cells with dendritic epidermal Tcells. Semin. Immunol. 1996, 8:333-339.
46. Travers J.B., Kozman A., Mousdicas N., Saha C., Landis M., Al-Hassani M., Yao W., Yao Y., Hyatt A.M., Sheehan M.P., et al. Infected atopic dermatitis lesions contain pharmacologic amounts of lipoteichoic acid. J.Allergy Clin. Immunol. 2010, 125:146-152. e141-142.
47. Volz T., Kaesler S., Biedermann T. Innate immune sensing 2.0 - from linear activation pathways to fine tuned and regulated innate immune networks. Exp. Dermatol. 2012, 21:61-69.
48. Volz T., Skabytska Y., Guenova E., Chen K.M., Frick J.S., Kirschning C.J., Kaesler S., Röcken M., Biedermann T. Nonpathogenic bacteria alleviating atopic dermatitis inflammation induce IL-10-producing dendritic cells and regulatory Tr1 cells. J.Invest. Dermatol. 2014, 134:96-104.
49. Wanke I., Skabytska Y., Kraft B., Peschel A., Biedermann T., Schittek B. Staphylococcus aureus skin colonization is promoted by barrier disruption and leads to local inflammation. Exp. Dermatol. 2013, 22:153-155.
50. Wollenberg A., Zoch C., Wetzel S., Plewig G., Przybilla B. Predisposing factors and clinical features of eczema herpeticum: a retrospective analysis of 100 cases. J.Am. Acad. Dermatol. 2003, 49:198-205.
51. Zea A.H., Rodriguez P.C., Atkins M.B., Hernandez C., Signoretti S., Zabaleta J., McDermott D., Quiceno D., Youmans A., O'Neill A., et al. Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: a mechanism of tumor evasion. Cancer Res. 2005, 65:3044-3048.